A. Magnan

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Geoffrey Chupp, Eric Bradford, Frank C. Albers et al. · The Lancet Respiratory Medicine · 2017 · 590 citations

Medicine, Pharmacology, Pharmacotherapy +14

Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients

Marc Humbert, Gianpaola Monti, Muriel Fartoukh et al. · European Respiratory Journal · 1998 · 297 citations · Full text

Medicine, Molecular Biology, Molecular Virology +10

Allergic <i>vs</i> nonallergic asthma: what makes the difference?

S. Romanet‐Manent, D. Charpin, A. Magnan et al. · Allergy · 2002 · 236 citations

Life Sciences, Internal Medicine, Allergy +11

Assessment of the Th1/Th2 Paradigm in Whole Blood in Atopy and Asthma: Increased IFN- γ –producing CD8+ T Cells in Asthma

A. Magnan, Laurent Mély, Christophe Camilla et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 235 citations

Life Sciences, Immunology, Allergy +14

Research needs in allergy: an EAACI position paper, in collaboration with EFA

Nikolaos G. Papadopoulos, Ioana Agache, Sevim Bavbek et al. · Clinical and Translational Allergy · 2012 · 207 citations · Full text

Life Sciences, Chronic Disease Prevention, Immunology +7